Tezepelumab (anti-TSLP)
Tezepelumab (anti-TSLP) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma[1].
Product Specifications
CAS Number
1572943-04-4
Product Name Alternative
AMG 157 (anti-TSLP) ; MEDI 19929 (anti-TSLP) ; Tezepelumab-ekko (anti-TSLP)
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tezepelumab-anti-tslp.html
Purity
99.0
Solubility
H2O
Smiles
[Tezepelumab(anti-TSLP)]
Molecular Weight
(144.6 kDa)
References & Citations
[1]Menzies-Gow A, et, al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021 May 13;384 (19) :1800-1809.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
P27 / KIP1 (SX53G8), CF740 conjugate, 0.1mg/mL
CD50 (ICAM-3) (101-1D2), CF647 conjugate, 0.1mg/mL
CD16 (C16/1045), CF488A conjugate, 0.1mg/mL
CD50 (ICAM-3) (186-2G9), CF640R conjugate, 0.1mg/mL
